A notable advancement in diabetes treatment is emerging with the introduction of tirzepatide at a dosage of 45mg. This new offering builds upon the existing success of tirzepatide, a dual GIP and GLP-1 agonist, and https://abelskeo585979.muzwiki.com/277579/revolutionary_development_tirzepatide_strength_for_diabetes_management